ReviewPathophysiological role of prostaglandin E synthases in liver diseases
Introduction
PGE synthase (PGES) is a terminal enzyme that synthesises prostaglandin E2 (PGE2). PGE2 is one of the most common prostanoids produced by many cells and tissues and is important in metabolism. In addition to PGESs, upstream phospholipase A2 and cyclooxygenase (COX) play important roles in the synthesis of PGE2 [[1], [2], [3]]. Three types of PGESs, namely microsomal PGES-1 (mPGES-1) and -2 (mPGES-2) and cytosolic PGES, have been discovered to be involved in PGE2 synthesis. However, the role of cytosolic PGES in the development of liver diseases remains unclear. mPGES-1 and mPGES-2 were found to be expressed in the liver and involved in liver disease [4,5]. Notably, mice with related enzyme deletions have been engineered for further research of their pathophysiological roles [6]. This review summarises the roles of the PGESs, particularly mPGES-1 and mPGES-2, in liver diseases such as viral hepatitis and Fas- and lipopolysaccharide (LPS)-induced liver injury.
Section snippets
Prostaglandin e synthases (PGESs)
mPGES-1 is a glutathione (GSH)-dependent membrane-bound enzyme that was initially detected in LPS-stimulated macrophages in 1999 [7]. It is expressed at low levels in normal tissues but at higher levels in inflamed tissues [8]. Among PGESs, only mPGES-1 is highly expressed in the presence of a proinflammatory stimulus [1]. Although COX-2 was once regarded as a useful target for treated related liver diseases, its targeting has been reported to cause many side effects, particularly in the renal
Conclusion
In this review, we summarise the role of PGESs, mPGES-1, and mPGES-2 in different types of liver diseases, such as viral hepatitis, NAFLD, Fas-induced injury, and drug-induced injury. However, the specific function of mPGES-1 in inflammation is unclear because the role of mPGES-1 differs in inflammation caused by different proinflammatory factors [18,24,30]. Currently, related studies indicate that mPGES-1 deficiency contributes to the recovery from liver injury or tumour clearance [47].
Declaration of Competing Interest
The authors declare that they have no conflicts of interest.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (grant no. 81603179), China Postdoctoral Science Special Foundation (grant no. 2018T110555), and Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (grant no. PPZY2015B161).
References (53)
- et al.
Phospholipase A2 enzymes
Prostaglandins Other Lipid Mediat.
(2002) - et al.
Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways
J. Biol. Chem.
(1999) - et al.
Identification and characterization of a novel type of membrane-associated prostaglandin E synthase
Biochem. Biophys. Res. Commun.
(2002) - et al.
Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models
Biochimie.
(2010) - et al.
Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders
Biochem. Pharmacol.
(2015) - et al.
Cardiovascular biology of microsomal prostaglandin E synthase-1
Trends Cardiovasc. Med.
(2010) Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro
J. Biol. Chem.
(2013)- et al.
Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1
J. Biol. Chem.
(2004) - et al.
15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter
Biochem. Pharmacol.
(2014) - et al.
Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways
J. Hepatol.
(2008)
Stimulation of fat accumulation in hepatocytes by PGE₂-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis
Lab. Invest.
Protective strategies against ischemic injury of the liver
Gastroenterology
Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice
J. Hepatol.
The regulatory mechanism involved in the prostaglandin E2 disposition in carbon tetrachloride-induced liver injury
Prostaglandins Leukot. Essent. Fatty Acids
Bone marrow stromal cells attenuate LPS-induced mouse acute liver injury via the prostaglandin E 2-dependent repression of the NLRP3 inflammasome in Kupffer cells
Immunol. Lett.
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
J. Biol. Chem.
mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2
J. Hepatol.
Hepatocellular carcinoma
Lancet.
Hepatocellular carcinoma: recent trends in the United States
Gastroenterology
Molecular pathogenesis of human hepatocellular carcinoma
Adv. Cancer Res.
Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases
Clin. Immunol.
Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology
Annu. Rev. Biochem.
Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma
Liver Int.
Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
Proc Natl Acad Sci U S A.
Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells
J. Immunol.
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
J. Clin. Invest.
Cited by (3)
Honey polyphenols: regulators of human microbiota and health
2022, Food and Function
- 1
These authors contributed equally to this work.